Last reviewed · How we verify
Physician based insulin regime — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Physician based insulin regime (Physician based insulin regime) — Shanghai Zhongshan Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Physician based insulin regime TARGET | Physician based insulin regime | Shanghai Zhongshan Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Physician based insulin regime CI watch — RSS
- Physician based insulin regime CI watch — Atom
- Physician based insulin regime CI watch — JSON
- Physician based insulin regime alone — RSS
Cite this brief
Drug Landscape (2026). Physician based insulin regime — Competitive Intelligence Brief. https://druglandscape.com/ci/physician-based-insulin-regime. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab